C595 mAb has been used in immunoassays for the measurement of soluble MUC1 in breast cancer patients (Price et al, 1992; Dixon et al, 1993) and for in vivo immunoscintigraphy (Symonds et al, 1992; Perkins et al, 1993). This evidence concerns the gene MUC1 and breast carcinoma.